- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 215/36 - Sulfur atoms
Patent holdings for IPC class C07D 215/36
Total number of patents in this class: 315
10-year publication summary
|
10
|
26
|
18
|
23
|
29
|
24
|
21
|
14
|
22
|
8
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Agios Pharmaceuticals, Inc | 200 |
15 |
| Amgen Inc. | 3779 |
11 |
| Bristol-myers Squibb Company | 5080 |
8 |
| Novartis AG | 11238 |
7 |
| Jiangsu Hengrui Medicine Co., Ltd. | 780 |
7 |
| Janssen Pharmaceutica N.V. | 3839 |
6 |
| Hinova Pharmaceuticals Inc. | 81 |
6 |
| Pharmaxis Ltd | 43 |
6 |
| Oxford Drug Design Limited | 9 |
6 |
| Galapagos NV | 304 |
5 |
| Galderma Research & Development | 440 |
5 |
| Korea Research Institute of Chemical Technology | 1266 |
5 |
| Merck Patent GmbH | 5909 |
4 |
| National Cancer Center | 292 |
4 |
| The University of Melbourne | 499 |
4 |
| AbbVie Global Enterprises Ltd. | 16 |
4 |
| F. Hoffmann-La Roche AG | 7958 |
3 |
| Monsanto Technology LLC | 7905 |
3 |
| Massachusetts Institute of Technology | 9795 |
3 |
| Baylor College of Medicine | 875 |
3 |
| Other owners | 200 |